Socrates (Acute Stroke Or Transient IsChaemic Attack TReated with Aspirin or Ticagrelor and Patient OutcomES) is an event-driven global clinical trial involving patients in 33 countries.
Contacts Media Enquiries Neil Burrows UK/Global Vanessa Rhodes UK/Global Karen Birmingham UK/Global Jacob Lund Sweden Michele Meixell US Investor Enquiries UK Thomas Kudsk Larsen Eugenia Litz RIA Nick Stone cvmd Craig Marks Finance Christer Gruvris Consensus Forecasts US Lindsey Trickett Oncology, ING Mitch Chan Oncology.
On a day when leading shares are surging ahead, mainly due to the pound tumbling to a new 31 year low and boosting exporters, AstraZeneca is heading in the other direction.
In the second half of 2016, data are expected from the ongoing euclid trial in peripheral arterial disease (PAD).For more information please visit:.The trials encompass a wide range of CV disorders, including coronary artery disease (pegasus-timi 54 peripheral arterial disease (euclid) and patients with type-2 diabetes at high risk of CV events (themis).Call your doctor right away if you have any signs or symptoms of bleeding while taking brilinta, including: severe, uncontrollable bleeding; pink, red, or brown urine; caixa economica federal comprovante de rendimentos imposto de renda 2018 vomit that is bloody comprovante de regularidade justiça do trabalho or looks like coffee grounds; red or black stool; or if you cough up blood.Euclid is the fourth trial to read-out from the parthenon programme, assessing the potential.While you take brilinta, you may bruise and bleed more easily and be more likely to have nosebleeds.
If you stop brilinta because of bleeding, or for other reasons, your risk of a heart attack or stroke may increase.
We had only around 200m in our numbers for this indication by 2021 anyway so the impact on earnings is small for us (less than 1) although others may have been more optimistic.
Fewer events were observed.
Your doctor should tell you when to start taking brilinta again, as soon as possible after surgery.Brilinta brilique in the treatment of atherothrombotic conditions.Its shares are down 21p.20 after it said its heart drug Brilinta had failed to help patients with circulatory problems in their legs, showing no benefits over an older blood thinning treatment, Sanofis Plavix.Brilinta and Brilique are registered trademarks of the AstraZeneca group.Call your doctor if you have new or unexpected shortness of breath or any side effect that bothers you or that does not go away.Treatment with Brilinta / Brilique 60mg may be started as continuation therapy after an initial one-year treatment with Brilinta / Brilique 90mg and aspirin or other dual anti-platelet therapy.Do not take brilinta if you have a history of bleeding in the brain, are bleeding now, quanto recebe um procurador do trabalho or are allergic to ticagrelor or any of the ingredients in brilinta.About, brilinta / Brilique Brilinta / Brilique is a direct-acting P2Y12 receptor antagonist in a chemical class called (cptps).